SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is experiencing significant upward momentum as its Amtagvi therapy demonstrates "remarkable" revenue growth and pipeline progress, pushing the stock past key technical levels and intensifying community speculation about a massive short squeeze.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is sharply higher as escalating Middle East tensions and concerns over the Strait of Hormuz disrupt global supply, driving crude oil prices to multi-year highs. The community is actively debating the sustainability of this rally and the potential for policy interventions to curb the price surge.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is surging after reporting strong Q4 earnings and issuing robust guidance, projecting accelerating data center and AI-driven revenue growth, which has led to numerous analyst upgrades. The community is buzzing about Marvell's pivotal role in AI infrastructure, from hyperscaler custom chips to optical connectivity, and the potential for S&P 500 inclusion.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is experiencing extreme volatility and divided opinion amid escalating Middle East tensions, including Strait of Hormuz disruptions and Qatar's LNG production halt, with bulls forecasting massive price spikes while bears highlight ample US supply and export limitations.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending as crude oil prices near $90 a barrel amid escalating Middle East tensions and warnings of potential $100-$150 oil. The community anticipates a significant short squeeze due to high short interest and a low float, drawing comparisons to its past explosive runs during similar geopolitical events, though some express frustration it hasn't "flown" like other oil stocks yet.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community discussion linking recent geopolitical actions, particularly in Iran, to rising oil prices and broader economic instability. These concerns are frequently attributed to the current administration's policies, with recent insider share sales also fueling bearish sentiment around the stock.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as surging oil prices, fueled by escalating geopolitical tensions, and disappointing jobs data are creating significant market jitters. The community is sharply divided, with many anticipating further downside and urging caution heading into the weekend, while some opportunistic buyers eye dips.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following strong earnings and significantly raised long-term guidance for its AI chip revenue, fueled by new partnerships with major AI players, leading the community to discuss its impressive strength as a semiconductor giant in a challenging market.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as heightened geopolitical tensions amplify the focus on defense drone technology, with the community actively discussing potential large government contracts and recent collaborations for counter-drone innovations. Strong bullish sentiment is fueled by speculation around "Drone Dominance" initiatives and the company's Black Widow and maritime drone platforms.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending after agreeing to a significant premium acquisition by Servier, generating widespread excitement within the community regarding the strategic expansion in pediatric low-grade glioma. Institutional activity and short squeezes are amplifying the conversation around this major biotech M&A event.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Propel Bio Management LLC Sells 370,000 Shares of Phathom Pharmaceuticals, Inc. $PHAT

Propel Bio Management LLC decreased its holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 40.1% during the 3rd quarter, according to the company in its most recent filing with...

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036)  DelveInsight

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight H. pylori Infections Market in the 6MM to Observe...

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 6.5% - Should You Sell?

Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 6.5% - Here's Why...

Phathom Pharmaceuticals (NASDAQ:PHAT) Posts Earnings Results, Beats Expectations By $0.01 EPS

Phathom Pharmaceuticals (NASDAQ:PHAT - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09...

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Expected to Rise, Guggenheim Analyst Says

Guggenheim raised their target price on Phathom Pharmaceuticals from $20.00 to $25.00 and gave the company a "buy" rating in a research report on Friday...

Phathom Pharmaceuticals Q4 Earnings Call Highlights

Phathom Pharmaceuticals (NASDAQ:PHAT) reported fourth-quarter and full-year 2025 results that management said came in at the better end of previously communicated guidance ranges, while also...

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates

Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of +11.11% and +0.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Up 14.3% on Earnings Beat

Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Up 14.3% Following Strong Earnings...

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of +18.18% and +15.49%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives Average Rating of "Moderate Buy" from Analysts

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine brokerages that are currently covering the stock, MarketBeat...

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

PHAT
Phathom Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PHAT News

PHATPhathom Pharmaceuticals Inc